Market Intelligence

Mind Stock Analysis Mind Technology Inc. 2.51 Dip 8.14 Price Trend Review 20260401 Is Newamsterdam Namsw Stock Attractive Now Price At 23.71 Up 12.53 20260407 What Events Could Move Mfs Mcr Stock Next Price At 6.00 Up 0.67 20260408 Is First Fwrg Stock Declining Price At 10.82 Up 0.60 20260406 Is SANUWAVE Health SNWV stock in a good position today SANUWAVE Health posts 413pct EPS beat vs estimates Altisource ASPSZ Stock ExDividend Play In Focus 20260420 ONTF ON24 notches wide Q4 2025 EPS beat over analyst estimates with shares posting minor daily gains Alphabet Inc GOOGL AI Infrastructure Tailwinds Strengthen As 16B Oracle Data Center Financing Closes SpaceX IPO Faces Caution as Market Analysts Flag Key Risks Vertiv Expands Power Protection Portfolio with Launch of Vertiv PowerUPS 100 Standby Series in North America Indian Mid and SmallCap Indices Rally Amid Global Headwinds But Sustainability in Doubt Prediction Markets Signal Rising Odds of Fed Rate Hike by July 2027 Snowflake Builds AI Turnaround Case Amid Evolving Data Landscape Meta Shares Decline Following Quarterly Results Iran Internet Disruptions Weigh on User Growth GHI Q1 2026 Earnings EPS Falls Short of Estimates Shares Edge Higher Despite Miss Apollo Global Management APO Q1 2026 Earnings EPS Misses by 05 Amid Mixed Market Signals Root Inc ROOT Q1 2026 Earnings EPS Beats Estimates by 1436 as Profitability Surges PDPA Q4 2025 Earnings EPS Slightly Below Estimates Preferred Stock Unchanged RVLV Q1 2026 Earnings EPS Beats Estimates Stock Rises 42 PSMT Q1 2026 Earnings EPS Beats Estimates Slightly Stock Edges Higher Medline Inc MDLN Gains 268 as Stock Approaches Key Resistance Zone Boyd Gaming BYD Edges Higher as Stock Holds Above Support BLSH Retreats Bearish Momentum Testing Support Levels for Bullish Ordinary Shares Graphic Packaging GPK Surges 388 as Stock Tests Key Resistance Near 1180 Algonquin Power Utilities AQN Declines 125 as Selling Pressure Persists Near Key Support NOA Q1 2026 Earnings EPS Misses Estimates as Stock Declines 332 INAB Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Stage Company Advances Pipeline Crescent Biopharma Inc CBIO Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline FMAO Q1 2026 Earnings EPS Surpasses Estimates by 38 Amid Steady Operations Energy Focus Q4 2024 Earnings Narrowed Loss Reflects Ongoing Cost Controls HRTX Q1 2026 Earnings EPS Misses Estimates Stock Declines on WiderThanExpected Loss